Speaker Details

Andrew Blauvelt, MD, FAAD

Andrew Blauvelt, MD, FAAD

SESSIONS

S043 Psoriasis
Mar 29, 2026 1:00 PM - 4:00 PM Four Seasons 3

DISCLOSURES

AbbVie – Consultant(Honoraria); Almirall – Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); AnaptysBio – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Arcutis, Inc. – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Consultant(Honoraria), Speaker(Honoraria); Incyte Corporation – Consultant(Honoraria); Janssen-Ortho Inc. – Consultant(Honoraria); Leo Pharma – Speaker(Honoraria); Leo Pharma Inc – Consultant(Honoraria); Lipidio Pharmaceuticals – Stockholder Private Company(Stock); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Pfizer Inc. – Consultant(Honoraria); Regeneron – Consultant(Honoraria); Sanofi – Consultant(Honoraria), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria), Speaker(Honoraria);